Trends in Antiretroviral Drugs Prescribing at Public Health Facilities in Ethiopia: Compliance to Treatment Guidelines Authors: Hailu Tadeg and Negussu.

Slides:



Advertisements
Similar presentations
Indicators for monitoring ARV treatment outcomes.
Advertisements

Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Results Introduction Background and Objectives  Identifying effective and cost-effective ways to improve adherence to antiretroviral therapy (ART) is.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Treatment challenges of 2 nd /3 rd line HIV/AIDS, hepatitis-C in Seychelles BY DR LOUINE MOREL.
Summary Slide Presentation Principles of HIV drug resistance for clinical management in South Africa Stott K, Michel J, de Oliveira T. Principles of HIV.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.
Cost-effectiveness of different starting criteria of antiretroviral therapy in Mexico. Caro Y., Colchero A., Valencia A., Bautista-Arredondo S., Sierra.
The Role of the IATT Optimal Paediatric ARV Formulary and Considerations for New Product Introduction Nandita Sugandhi, M.D. Clinton Health Access Initiative.
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT) Implications.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
Using Mobile Technology to Strengthen HIV/AIDS Management in Remote Areas Authors: (1)Kunda, Mwape; (2)Pereko, Dawn; (2)Sumbi, Victor; (2)Mwinga, Samson;
1Management Sciences for Health A LABORATORY BASED APPROACH TO REDUCE LOSS TO FOLLOW UP OF HIV POSITIVE CLIENTS.
ABSTRACT Background: A retrospective medical record review was conducted to evaluate implementation of the Public Health Service recommendations for laboratory.
Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose 1 *, Hinda Ruton 1,
Tracking of Inter-Facility Patient Transfers and Retention on Antiretroviral Treatment in Namibia Presenter Naita Nashilongo Ministry of Health and Social.
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
ICAP Quarterly Master Slide Set April-June Site Census What: Ongoing, real-time inventory of all planned, current, and closed ICAP sites. Supported.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Orientation on HIV care and ART Recording and Reporting System.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Integrating ART/PMTCT services into MNCH services to enhance test & treat strategy for HIV infected pregnant and lactating women (Option B+) WHO Satellite.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Dr Ihor Perehinets MD, MPH National Technical Officer WHO CO in Ukraine Pharmacovigilance (PV) in HIV treatment in Ukraine: Situation Analysis Dar es Salaam.
Authors: Lates JA, Shiyandja NN Funding Institution: Ministry of Health and Social Services, Namibia Title: Third National Survey on the Use of Drugs in.
Sub module 1 Introduction to HIV care and ART recording and reporting system.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
ICIUM 2004-CHIANG MAI SURVEY REPORT ON RATIONAL USE OF DRUGS In 30 Primary Health Centres of Tamilnadu, India.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
KENYATTA NATIONAL HOSPITAL. PROMOTING RATIONAL USE OF ANTI-RETROVIRALS (ARV) AT KENYATTA NATIONAL HOSPITAL (KNH) IN KENYA BY OGILE ELIZABETH BPharm Pg.
Optimizing the Cost and Quality of HIV / AIDS Care and Treatment Anil Soni, Clinton HIV / AIDS Initiative 19 th Board Meeting, Geneva 6 May 2009.
THE RELATIONSHIP BETWEEN DRUG SUPPLY AND PRESCRIBING PATTERNS IN DISTRICT HOSPITALS IN UGANDA Ogwal-Okeng JW, Obua C, and Anokbonggo WW. International.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
ACTG 5142: First-line Antiretroviral Therapy With Efavirenz Plus NRTIs Has Greater Antiretroviral Activity Than Lopinavir/Ritonavir Plus NRTIs Slideset.
Justine Mirembe MD, MPH ICASA, 5th December 2011
Module 4 (e) Pregnancy and Breast Feeding
Daniel Meressa, M.D. Global Health Committee St. Peter’s Hospital
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
Community ART delivery models for high patient’s retention and good
By Nour Elhouda Ata Alla Assistant Professor, Consultant Paediatrician
Introduction to Clinical Pharmacy
Poster P200 18th Annual Conference of the British HIV Association (BHIVA), 18 – 20th April 2012, Birmingham, UK An analysis of the reasons for switching.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Thokozani Kalua MBBS MSc Malawi Ministry of Health
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
USAID STRENGTHENING THE CARE CONTINUUM PROJECT (The Care Continuum)
KENYATTA NATIONAL HOSPITAL
Management and Development for Health (MDH)
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Presentation transcript:

Trends in Antiretroviral Drugs Prescribing at Public Health Facilities in Ethiopia: Compliance to Treatment Guidelines Authors: Hailu Tadeg and Negussu Mekonnen Presenting Author: Hailu Tadeg (B.Pharm, MSc, MPH) Management Sciences for Health Strengthening Pharmaceutical Systems (MSH/SPS) Ethiopia

Introduction  With the advent of ARV drugs, HIV/AIDS has become a treatable chronic disease  Currently, more than 4 million people are receiving ART in low- and middle-income countries  In Ethiopia, HIV was first reported in 1984  In 2008, an estimated 1.03 million people were living with HIV  More than people get newly infected every year, and an estimated 290,000 people need ART  Ethiopia started fee-based ART in 2003 and launched free ART in January 2005  As of March 2010, 511 health facilities (142 hospitals and 369 health centers) provide ART service throughout the country  Out of all ART clients, about 58% are female.  In terms of drug combination, the majority of patients are on 1 st line regimen while only 1% (1,079) of patients were switched to a 2 nd line regimen

Introduction (2)  Given the life-long nature of ART, its costs and public health implications, adequate monitoring of the program is essential  Evidence-based treatment guidelines are increasingly used to guide clinicians’ medical care decisions  The use of combination ARV medications has transformed HIV infection into a treatable chronic infection  However, the complexity of ARVs has reduced adherence and increased drug– drug interactions and metabolic toxicities.  Some ARV combinations are discouraged because of excess toxicities, regimen complexity, or adverse drug interactions  The FMOH of Ethiopia has revised the STG taking into account these complexity of ARVs management  The latest STG for ART was last revised in March 2008, launched nationally and used to guide national trainings on ART  The guideline was then distributed to prescribers and dissemination further strengthened during supportive supervision and mentoring visits  Understanding of prescribing patterns in comparison with STGs might show changes in practice and will help in suggesting the need for early interventions

Objectives  In spite of its importance the adherence of prescribers to STG for ART has not been systematically studied in Ethiopia.  The current study is conducted to fill this gap General Objective: To investigate trends in the prescribing of antiretroviral drugs in public health facilities and the level of compliance of prescribers to ART guideline Specific Objectives: To study trends in the patterns of choices of preferred 1 st line, alternative 1 st line and 2 nd line regimens by prescribers To examine the trends in the proportion of patients on D4T versus TDF based regimens To identify differences in ARVs prescribing trends amongst regions To compare ARVs prescribing practices and trends between hospitals and health centers

Methods  Data was extracted from the monthly activity reports of ART pharmacy received in October of the years 2008, 2009 and 2010  Data on regimens was compiled by region and level of health facility  The regimens were evaluated for compliance with the recommendations of the national STG DesignRetrospective descriptive study SettingART Pharmacies Seven regions in Ethiopia PopulationAll public health facilities providing ART services Sample Size154 Hospitals (70 Hospitals and 84 Health Centres) Inclusion Criteria All ART sites that had consistently reported on October of 2008, 2009, 2010.

Results Regimen Type Year #%#%#% D4T/3TC/NVP D4T/3TC/EFV ZDV/3TC/NVP ZDV/3TC/EFV TDF/3TC/NVP TDF/3TC/EFV ABC/3TC/NVP ABC/3TC/EFV ABC/3TC/ZDV ABC/3TC/LOP/r ABC/ddI/LOP/r ZDV/ddI/LOP/r ZDV/3TC/LOP/r D4T/3TC/LOP/r TDF/3TC/LOP/r TDF/3TC/ZDV TDF/ddi/LOP/r TDF/3TC/ABC/Lop/r Others Total50, , ,  Majority of prescribed regimens are a combination of nucleoside and non- nucleoside analogues  About 98% of prescribed regimens are picked from within the STG.  More than 97% of patients are taking three antiretroviral drug combinations. Aggregate number and percentage of patients on each regimen

Result (2)  # Patients on preferred first line regimen has increased from 32% in 2008 to 49% in 2010 while those on alternative first line regimen declined from 66% to 48%.  % of patients on regimens not recommended by the guideline increased by more than 5-fold between 2008 and 2010

Result (3)  The actual prescribing practice follows the recommended trends.  But, does this prove compliance to the STG?  Large proportion of new patients are being treated with D4T based regimen against guidelines recommendations!

Result (4)  Prescribing patterns follows more or less similar trends  The shift from D4T- based to TDF and ZDV- based regimens is slower in AA, Amhara and Tigray  The trend in Diredawa and Harari much better than other regions

Result (5)  Although the new STG recommend TDF-based regimen as preferred first option, the proportion of patients on this regimen is still very low in both hospitals (14%) and HCs (8%)  Overall prescribing practice follows similar trends irrespective of the level of health facility  Proportion of patients on D4T-based regimens is consistently higher in HCs than Hospitals  The shift to TDF-based regimens appears to be faster in HCs

Conclusion  A significant number of patients are still on alternative first-line regimens  Large number of patients including newly enrolled ones are on D4T-based regimens signifying an important safety and adherence concerns.  Differences in prescribing practice exist between regions and between hospitals & health centres  Prescribing combination of ARVs that are not recommended by STG increased over the study period  Overall, the findings of this study indicate that compliance to ART guidelines requires significant improvement.  Therefore, additional interventions, including revision of STG, are required to improve compliance to ART guideline recommendations

Thank You!!!